NCT01645852View on ClinicalTrials.gov

A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection

NACompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Nonalcoholic Fatty Liver DiseaseHepatic SteatosisSteatohepatitis
Interventions
DIETARY_SUPPLEMENT

Optifast 800

Five units of Optifast 800 plus an unlimited volume of calorie-free fluids per day for one week prior to hepatic resection.

Trial Locations (3)

01655

UMass Memorial Medical Center, Worcester

03756

Dartmouth-Hitchcock Medical Center, Lebanon

05401

Fletcher Allen Health Care, Burlington

All Listed Sponsors
lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT01645852 - A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection | Biotech Hunter | Biotech Hunter